Clinical Trial Update: Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating PD-1 blockade in conjunction with dendritic cell/myeloma vaccines after stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED